A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Clinical trial NCT02437890 · COMPLETED

Trial details

NCT number: NCT02437890
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2015-07-01
Primary completion: 2018-01-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.